People · Operator

Agnes Rey-Giraud

Named in public records as an officer, director or promoter · active 2013–2020 · Other Technology, Medical Devices

2
Companies
5
Filings
$25.9M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
GoodRx Holdings, Inc.Other TechnologySeries A$19.7M$284.6M2020
Acera Surgical, Inc.Medical DevicesSeries A$6.2M$123.6M2013
Operator network

Agnes Rey-Giraud at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Christopher Adams · 4 companies · 1 sharedChristopher AdamsAdam Karol · 2 companies · 1 sharedAdam KarolDipanjan Deb · 2 companies · 1 sharedDipanjan DebJacqueline Kosecoff · 2 companies · 1 sharedJacqueline Koseco…Karsten Voermann · 2 companies · 1 sharedKarsten VoermannAndrew Slutsky · 1 companies · 1 sharedAndrew SlutskyDoug Hirsch · 1 companies · 1 sharedDoug HirschGregory Mondre · 1 companies · 1 sharedGregory MondreStephen LeSieur · 1 companies · 1 sharedStephen LeSieurTrevor Bezdek · 1 companies · 1 sharedTrevor BezdekJulie Hedenkamp Cochran · 1 companies · 1 sharedJulie Hedenkamp C…Matthew MacEwan · 1 companies · 1 sharedMatthew MacEwanMatthew Reagan MacEwan · 1 companies · 1 sharedMatthew Reagan Ma…GoodRx Holdings, Inc. · $19.7M raisedGoodRx Holdings, Inc.Acera Surgical, Inc. · $6.2M raisedAcera Surgical, Inc.Agnes Rey-GiraudAR
Agnes Rey-Giraud Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Agnes Rey-Giraud on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Christopher Adams14
Dipanjan Deb12
Jacqueline Kosecoff12
Karsten Voermann12
Adam Karol12
Doug Hirsch11
Julie Hedenkamp Cochran11
Matthew MacEwan11
Matthew Reagan MacEwan11
Stephen LeSieur11
Trevor Bezdek11
Gregory Mondre11
Andrew Slutsky11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.